"Acute Stroke Treatment Trials : Enhancing Development, Cooperation and Approval"


STAIR IV Sponsors

Altana Pharma AG

APT Therapeutics  


Axaron Bioscience

AG Bayer HealthCare

Biogen IDEC

Biotechnology Value Fund LP

Boehringer Ingelheim Pharma, Inc.

Bristol-Myers Squibb

Cato Research, LTD


CereMedix, Inc.

Concentric Medical


DDC Group

Ebewe Pharma

Eisai Medical Research

Ekos Corporation

Eli Lilly & Co.

Empire Pharmaceuticals, Inc.

Ferrer Internacional, S.A.

Fujisawa Healthcare, Inc.

Genencor International, Inc.

Genentech, Inc.

Indevus Pharmaceuticals

Johnson & Johnson

Kyowa Hakko Kogyo

Merck Research Laboratories

Mitsubishi Pharma America  

Novo Nordisk A/S  


Pfizer Global Research & Development

PhotoThera, Inc.

Radiant Medical, Inc.

Serono, Inc.



Suntory Pharmaceutical, Inc.

Taisho Research & Development  

Thrombogenics LTD        

Wyeth Research

Yamanouchi America 

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2020 The Stroke Group